SEC Company Response from Co-Diagnostics, Inc. (CODX) (CIK 0001692415) (CODX) — Jul 12, 2017
Co-Diagnostics, Inc. (CODX) (CIK 0001692415)
Date: July 12, 2017 · CIK: 0001692415 · Accession: 0001477932-17-003264
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-217542
Letter
Re: Co-Diagnostics, Inc.
codx_corresp.htmJuly 11, 2017
Securities and Exchange Commission
450 Fifth Street, N.W.
Washington, D.C. 20549
Registration Statement on Form S-1
File No. 333-217542
Ladies and Gentlemen:
Pursuant to Rule 461 under the Securities Act of 1933, as amended (the “Securities Act”), the undersigned hereby join in the request of Co-Diagnostics, Inc. that the effective date of the above-captioned Registration Statement be accelerated to 5:30 p.m. on July 11, 2017, or as soon thereafter as practicable.
In connection with the Preliminary Prospectus distribution for the above-captioned issue, the prospective underwriters have confirmed that they are complying with the requirements of Rule 15c2-8 under the Securities Exchange Act of 1934, as amended.
The following information with respect to the distribution of the Preliminary Prospectus dated July 10, 2017 is furnished pursuant to Rule 460 of the Rules and Regulations of the Commission under the Securities Act, in connection with the request for acceleration of the effective date of the Registration Statement.
The undersigned have effected approximately the following distribution of copies of the Preliminary Prospectus, July 10, 2017, through the date hereof:
Preliminary Prospectus, dated July 10, 2017:
600 copies were distributed to prospective underwriters, institutional investors, dealers and others.
[Remainder of page intentionally left blank]
Very truly yours,
WallachBeth Capital, LLC
Show Raw Text
CORRESP 1 filename1.htm codx_corresp.htmJuly 11, 2017 Securities and Exchange Commission 450 Fifth Street, N.W. Washington, D.C. 20549 Re: Co-Diagnostics, Inc. Registration Statement on Form S-1 File No. 333-217542 Ladies and Gentlemen: Pursuant to Rule 461 under the Securities Act of 1933, as amended (the “Securities Act”), the undersigned hereby join in the request of Co-Diagnostics, Inc. that the effective date of the above-captioned Registration Statement be accelerated to 5:30 p.m. on July 11, 2017, or as soon thereafter as practicable. In connection with the Preliminary Prospectus distribution for the above-captioned issue, the prospective underwriters have confirmed that they are complying with the requirements of Rule 15c2-8 under the Securities Exchange Act of 1934, as amended. The following information with respect to the distribution of the Preliminary Prospectus dated July 10, 2017 is furnished pursuant to Rule 460 of the Rules and Regulations of the Commission under the Securities Act, in connection with the request for acceleration of the effective date of the Registration Statement. The undersigned have effected approximately the following distribution of copies of the Preliminary Prospectus, July 10, 2017, through the date hereof: Preliminary Prospectus, dated July 10, 2017: 600 copies were distributed to prospective underwriters, institutional investors, dealers and others. [Remainder of page intentionally left blank] 1 Very truly yours, WallachBeth Capital, LLC as Representative of the Several Underwriters By: /s/ Daniel Tapia Daniel Tapia Chief Compliance Officer Network 1 Financial Securities, Inc. as Representative of the Several Underwriters By: /s/ Damon Testaverde Damon Testaverde Managing Director 2